Iradimed stock hits all-time high of 104.67 USD
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Iradimed Co (IRMD)
Iradimed Co stock price live, this page displays NASDAQ IRMD stock exchange data. View the IRMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Iradimed Co real time stock price chart below.
What Is the Iradimed Co Stock Price Today?
The Iradimed Co stock price today is 95.97.
What Is the Stock Symbol for Iradimed Co?
The stock symbol for Iradimed Co is "IRMD."
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the NASDAQ stock exchange.
Is Iradimed Co a Good Stock to Buy?
Determining whether Iradimed Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRMD quote. (ISIN: US46266A1097)
What Is the Iradimed Co Stock Price Today?
The Iradimed Co stock price today is 95.97.
What Is the Stock Symbol for Iradimed Co?
The stock symbol for Iradimed Co is "IRMD."
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the NASDAQ stock exchange.
Is Iradimed Co a Good Stock to Buy?
Determining whether Iradimed Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRMD quote. (ISIN: US46266A1097)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.85
96.74
52 wk Range
47.48
104.93
Earnings results expected in 4 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.8596.74
52 wk Range
47.48104.93
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.12%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.12%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRMD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
99.00
Upside
+3.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Form 144 IRADIMED CORP For: 11 December
- Investing.com
- Iradimed stock hits all-time high at 100.55 USD
- Investing.com
- Form 144 IRADIMED CORP For: 9 December
- Investing.com
- Iradimed CEO Susi sells $487k in shares
- Investing.com
- Iradimed stock hits all-time high of 104.67 USD
- Investing.com
- Iradimed stock hits all-time high at 100.55 USD
- Investing.com
- Iradimed CEO Susi sells $487k in shares
- Investing.com
- Iradimed Co stock hits all-time high at 99.72 USD
- Investing.com
- Iradimed stock reaches all-time high at 98.24 USD
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Iradimed Co Company Profile
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Iradimed Co Earnings Call Summary for Q3/2025
- Iradimed Co reported Q3 2025 EPS of $0.47, beating forecasts by 2.17%, with revenue of $21.2 million exceeding estimates by 3.41%, marking 16th consecutive quarter of record revenues.
- Following the earnings release, stock surged 8.53% to $82.25 in pre-market trading, reflecting investor optimism about the company's performance and new product developments.
- The company's newly FDA-cleared 3870 IV pump system is expected to be a 'seminal event' according to CEO Roger Susi, with significant growth potential for 2026.
- Iradimed maintains a strong financial position with $53 million in cash and equivalents, 78% gross margin, and net income of $5.8 million for the quarter.
- Management projects Q4 revenue of $20.5-20.9 million and full-year 2025 revenue of $80-82.5 million, with expectations to reach $100 million revenue run rate in 2026.
Last Updated: 2025-11-03, 11:42 a/m
Read Full TranscriptCompare IRMD to Peers and Sector
Metrics to compare | IRMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 57.6x | 48.3x | −0.5x | |
PEG Ratio | 4.37 | 0.28 | 0.00 | |
Price/Book | 12.4x | 12.5x | 2.6x | |
Price / LTM Sales | 15.2x | 3.4x | 3.3x | |
Upside (Analyst Target) | 4.7% | 6.8% | 48.1% | |
Fair Value Upside | Unlock | 4.6% | 7.7% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 99.00
(+3.16% Upside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
0.47 / 0.46
Revenue / Forecast
21.20M / 20.50M
People Also Watch
FAQ
What Is the Iradimed Co (IRMD) Stock Price Today?
The Iradimed Co stock price today is 95.97
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Iradimed Co?
The stock symbol for Iradimed Co is "IRMD."
Does Iradimed Co Pay Dividends? What’s The Current Dividend Yield?
The Iradimed Co dividend yield is 2.12%.
What Is the Iradimed Co Market Cap?
As of today, Iradimed Co market cap is 1.23B.
What Is Iradimed Co's Earnings Per Share (TTM)?
The Iradimed Co EPS (TTM) is 1.65.
When Is the Next Iradimed Co Earnings Date?
Iradimed Co will release its next earnings report on Feb 10, 2026.
From a Technical Analysis Perspective, Is IRMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Iradimed Co Stock Split?
Iradimed Co has split 0 times.
How Many Employees Does Iradimed Co Have?
Iradimed Co has 160 employees.
What is the current trading status of Iradimed Co (IRMD)?
As of Feb 07, 2026, Iradimed Co (IRMD) is trading at a price of 95.97, with a previous close of 94.54. The stock has fluctuated within a day range of 94.85 to 96.74, while its 52-week range spans from 47.48 to 104.93.
What Is Iradimed Co (IRMD) Price Target According to Analysts?
The average 12-month price target for Iradimed Co is USD99.00, with a high estimate of USD100 and a low estimate of USD98. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +3.16% Upside potential.
What Is the IRMD Premarket Price?
IRMD's last pre-market stock price is 97.22. The pre-market share volume is 10.00, and the stock has decreased by 2.68, or 2.83%.
What Is the IRMD After Hours Price?
IRMD's last after hours stock price is 96.00, the stock has decreased by 0.03, or 0.03%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.